It has been a very disappointing day of trade for the S&P/ASX 200 index on Tuesday. In afternoon trade the benchmark index is down a sizeable 1.95% to 6,728.6 points.
Four shares that have defied the market sell off today are listed below. Here’s why they are pushing higher:
The FAR Ltd (ASX: FAR) share price is up 2% to 4.7 cents. This morning the oil and gas producer announced that the final Sangomar Field Development and Exploitation Plan was submitted to the Government of Senegal on December 2. The Development and Exploitation Plan outlines the full field multi-phase development of oil and gas and details how the Sangomar Field will be developed in a series of phases with plans for 645 mmboe to be developed.
The Medical Developments International Ltd (ASX: MVP) share price is up 2.5% to $7.28 despite there being no news out of the healthcare company. However, the Medical Developments International share price has been on fire this year thanks to positive developments in the United States and China for its Penthrox pain management product.
The MGC Pharmaceuticals Ltd (ASX: MXC) share price has jumped 6% higher to 3.5 cents. Investors have been buying the cannabis company’s shares after it announced the receipt of formal approval for the sale of CannEpil in Ireland. CannEpil is one of MGC Pharma’s Investigational Medicinal Products to treat drug resistant epilepsy. This makes it one of the first cannabinoid-based medicines approved for prescription and sale under the Irish Government’s Medical Cannabis Access Programme.
The Western Areas Ltd (ASX: WSA) share price is up 1% to $2.85. The catalyst for this gain was a broker note out of Morgans this morning. According to the note, the broker has initiated coverage on the nickel producer with an add rating and $3.39 price target. Morgans is positive on nickel due to its use in stainless steel and battery manufacturing.
The post Why FAR, Medical Developments, MGC Pharma, & Western Areas are pushing higher appeared first on Motley Fool Australia.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Medical Developments International Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019